Lilly seeks to expand pain pipeline with $1B acquisition
SiteOne Therapeutics is developing a non-opioid therapy that targets sodium ion channels in the human body to treat pain and sensory hyperexcitability disorders.
Health Care & Insurance
Articles
Weight-loss drugs may lower cancer risk in people with diabetes, study suggests
The findings were released Thursday by the American Society of Clinical Oncology and will be discussed at its annual meeting.
FDA to limit COVID vaccine approval to older adults, those with medical conditions
FDA leaders estimate more than 100 million Americans would still be eligible for the shots under the new framework.
Court of Appeals sends case involving Zionsville fertility doctor back to trial court
The Indiana Court of Appeals overturned a lower court’s July 2024 court order in a case involving Dr. Donald Cline, a retired Zionsville fertility doctor who was the subject of a 2022 Netflix documentary.
CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down
The Danish pharmaceutical company, which competes heavily with Indianapolis-based Eli Lilly and Co. in the weight-loss market, is leaving by “mutual agreement” with the company’s board of directors.
Historic Indiana Oxygen Co. Building lands medical tenant
The once-endangered 95-year-old building, which was moved to its current location in 1995, has been mostly vacant since the closure of Dunaway’s restaurant in late 2014.
Elevance investors reject pro-DEI shareholder proposal
Diversity, equity and inclusion, or DEI, efforts have become a debated topic in the corporate world and beyond this year.
Overdose deaths in United States fell last year in largest one-year decline on record
Experts say more research needs to be done to understand what drove the reduction, but they mention several possible factors.
Zimmer Biomet ‘cementless’ partial knee implant makes Indiana debut
The Zimmer Biomet Oxford Cementless Partial Knee System received FDA approval in November, although the implant has been used in more than 300,000 procedures outside the U.S.
UnitedHealth Group CEO steps down as insurer lowers, withdraws financial outlook
The nation’s largest health insurer suspended its full-year financial outlook due to higher-than-expected medical costs.
UPDATE: Roche Diagnostics to invest up to $550M in Indianapolis, adding hundreds of local jobs
The Swiss pharmaceutical and diagnostics giant said the move will establish the Indianapolis-based Roche Diagnostics site as a hub for manufacturing of its continuous glucose monitoring system.
Trump signs order setting 30-day deadline for drugmakers to lower prescription drug costs
The sweeping executive order sets a deadline for drugmakers to lower the cost of prescription drugs in the United States or face new limits over what the government will pay.
Trump promises to order that United States pay same price other nations do for some drugs
The proposal, expected to be announced by President Trump on Monday, will face fierce opposition from the pharmaceutical industry.
Lilly shuffles roles amid growth in U.S. investment, diabetes and obesity treatments
The company has announced more than $50 billion in new U.S. manufacturing investments since 2020.
Lilly chief scientist talks drugmaker’s new $4.5B campus, recruiting and innovation
Chief Scientific Officer Dr. Daniel Skovronsky talked with the IBJ about his hopes for the Lilly Medicine Foundry, which the Indianapolis-based drugmaker broke ground on this week.
Braun signs bill scrutinizing nonprofit hospital prices
House Bill 1004’s core pricing scrutiny targets hospital systems with $2 billion or more in net patient service revenue in the state.
Elanco ramps up debt repayment, sells future royalties of flea and tick medicine for human use
Greenfield-based Elanco Health on Monday announced the $295 million cash sale of future U.S. royalty and milestone rights for the human use of a medication typically used for dogs and cats.
Forté Sports Medicine and Orthopedics adds surgeons, Mooresville location
Carmel-based Forté Sports Medicine and Orthopedics now has 26 physicians and five offices in the Indianapolis area,
Lilly shares plunge after CVS Health drops Zepbound from preferred coverage
CVS Health’s pharmacy benefits manager said weight-loss drugs from rival drugmaker Novo Nordisk will become the preferred options on its standard formulary, or list of covered drugs, as of July 1.
UPDATE: Lilly shares tumble after missing analyst earnings expectations
The Indianapolis-based drugmaker also reaffirmed its 2025 revenue guidance but noted that the calculation was based on existing tariff and trade policies.